To compare the outcomes in young patients with multiple myeloma at diagnosis (<50 years) undergoing autologous or allogeneic hematopoietic stem cell transplant with older patients (≥50): progression-free and overall survival in a case match.
Study #: MM18-03a
Study Status: Published
Presentation(s)
2019, ASH (Oral)
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
Citation
Munshi PN, Vesole D, Jurczyszyn A, Zaucha JM, St. Martin A, Davila O, Agrawal V, Badawy SM, Battiwalla M, Chhabra S, Copelan E, Kharfan-Dabaja MA, Farhadfar N, Ganguly S, Hashmi S, Krem MM, Lazarus HM, Malek E, Meehan K, Murthy HS, Nishihori T, Olin RL, Olsson RF, Schriber J, Seo S, Shah G, Solh M, Tay J, Kumar S, Qazilbash MH, Shah N, Hari PN, D'Souza A.
Cancer. 2020, Dec 01: 126(23): 126(23):5077-5087. doi: 10.1002/cncr.33171. Epub 2020, Sep 23. PMCID:PMC8063213.
PubMed
PMID: 32965680
Abstract
Erratum to "Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma."
Citation
Munshi PN, Vesole D, Jurczyszyn A, Zaucha JM, St. Martin A, Davila O, Agrawal V, Badawy SM, Battiwalla M, Chhabra S, Copelan E, Kharfan-Dabaja MA, Farhadfar N, Ganguly S, Hashmi S, Krem MM, Lazarus HM, Malek E, Meehan K, Murthy HS, Nishihori T, Olin RL, Olsson RF, Schriber J, Seo S, Shah G, Solh M, Tay J, Kumar S, Qazilbash MH, Shah N, Hari PN, D'Souza A.
Cancer. 2021, Oct 15: 127(20): 127(20):3904. doi: 10.1002/cncr.33755. Epub 2021, Jul 13. PMCID:N/A.
PubMed
PMID: 34254668
Abstract
